Serum levels of IPA and IAA were lower in hospitalized patients with SARS-CoV-2 infection (n = 172) compared to healthy controls (n = 29) and levels were lowest in those with severe disease, while ILA levels were lower in COVID-19 patients but not in those with a fatal outcome to infection (Fig. S1). Here, TNFRSF9 is linked to COVID-19.